论文部分内容阅读
目的:探讨米非司酮联合米索前列醇终止10-16周妊娠的有效性与安全性。方法:选取近年来于我院行妊娠终止的58例健康女性作为研究对象,所有药流者妊娠时长为10-16周,第1、2天给予米非司酮药物,第3天配合使用米索前列醇药物,观察引产者引产情况与不良反应,总结联合药流法临床效果。结果:58例药流者联合应用米非司酮与米索前列醇行药物引产能够有效终止10-16周妊娠,且无严重的药副作用,患者痛苦较小,并发症发生率较低,安全性较高。结论:联合使用米非司酮与米索前列醇药物终止10-16周妊娠有效性、安全性均十分显著,且操作便易,临床推广价值较高。
Objective: To investigate the efficacy and safety of mifepristone combined with misoprostol in the termination of 10-16 weeks gestation. Methods: Fifty-eight healthy women whose pregnancies were terminated in our hospital in recent years were selected as study subjects. All pregnant women were given pregnancy for 10-16 weeks. Mifepristone was given on the first and second days, and misoprostol was used on the third day Prostate drug, observe the induction of labor induced labor and adverse reactions, summarize the clinical efficacy of the combination of medical methods. Results: The combination of mifepristone and misoprostol in 58 cases of drug flower can effectively terminate the pregnancy of 10-16 weeks with no serious side effects, less pain, lower complication rate and safety Higher. Conclusion: The efficacy and safety of combination of mifepristone and misoprostol in the termination of pregnancy of 10-16 weeks are very significant, and the operation is easy and the value of clinical popularization is high.